: iStockAnalyst.com Symbols Feed

Analyst Comments: Enzon Pharma, BHP Billiton, Lincoln Electric, Hologic, Ardea Biosciences, Gafisa, Buckeye Partners, Take-Two

Mon, 18 Aug 2008 18:50:00 GMT

Enzon Pharmaceuticals? (ENZN) key product Abelcet, a treatment for fungal infections, sales continued to deteriorate in 2008. Further, another major source of revenue, Royalty, is also under pressure from competition. However, sales in two other products, Oncaspar (for acute lymphoblastic leukemia) and Adagen (for severe combined immunodeficiency disease) are picking up momentum and offsetting the sales decline from Abelcet and Royalty. We are impressed with strong sales growth of Oncaspar. We expect total revenue to remain stable or experience modest growth in the coming years while the company is progressing well with its clinical developments. Enzon is also advancing its pipeline to drive long-term growth. We maintain our Hold rating on the shares. We see a balanced risk/reward profile for Enzon. In our view, there are limited near-term catalysts to[More...]

Analyst Comments: DST Systems, Home Diagnostics, OmniVision, Equifax, Third Wave Technologies, Regions Financial, Deckers Outdoor

Tue, 10 Jun 2008 21:03:08 GMT

DST Systems, Inc. (DST) was hit hard in the first quarter by the loss of share owner accounts that were converted to less profitable sub-accounts. We believe this is likely to be a headwind for the foreseeable future as mutual fund companies continue to offload this function to broker dealers. We maintain our Hold rating on DST shares and set our target price to $67.00. DST's leadership position and...[More...]

Periodicals Wrap-Up for Monday, June 9th

Mon, 09 Jun 2008 14:35:12 GMT

Submitted By Optiondragon[More...]

Oil, Lehman, Housing, & Fedspeak

Mon, 09 Jun 2008 13:57:27 GMT

Good morning. Premarket futures are holding steady and point to a higher open as oil pulls back and investors feel & hope that the negative reaction to Friday's jobs report was overblown. As expected, Lehman Brothers (LEH) preannounced a massive $2.8 bill[More...]

Hump Day

Wed, 12 Mar 2008 14:15:43 GMT

Good morning. As everyone tries to figure out how effective the latest action by the Fed will affect the credit markets and economy, premarket futures are pointing to a lower open.[More...]

Analyst Comments: Genuine Parts Company, Advance Auto Parts, Progressive Corporation, Hubbell, Inc.-B, Third Wave Technologies, Penn Virginia Resource Partners,

Wed, 30 Jan 2008 04:59:15 GMT

A Hold recommendation has recently been issued to automobile and industrial parts distributor Genuine Parts Company (GPC) by Zacks senior automobile industry analyst Paul Raman, CFA. Here's what his latest update had to say about it:'Genuine Parts Company has undertaken various initiatives such as product...[More...]

Biotech Company Raises Venture Capital, Will Move to Madison

Thu, 13 Aug 2009 07:51:00 GMT

Aug. 13--Flex Biomedical Inc., a privately held company developing treatments for orthopedic diseases, said it has raised $985,000 in Wisconsin, including a $150,000 loan from the state's Technology Venture Fund, and will move its operations to Madison from Boston.
Three of the state's early-stage investment groups -- Wisconsin Investment Partners in Madison, NEW Capital Fund in Appleton and Marquette University Golden Angels Network in Milwaukee -- have invested in the company.
Flex Biomedical, which employs three people, plans to begin clinical trials late next year or in early 2011 on a synthetic polymer to treat osteoarthritis, said Sal Braico, the company's chief executive, who has moved to Madison.

[More...]

Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.

Thu, 24 Jul 2008 13:10:00 GMT

Hologic, Inc. today announced the successful completion of the tender offer by its direct wholly-owned subsidiary, Thunder Tech Corp., for all outstanding shares of Third Wave Technologies, Inc. at a price of $11.25 per share in cash.[More...]

Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period

Thu, 17 Jul 2008 12:57:00 GMT

Hologic, Inc. and Third Wave Technologies, Inc. , today jointly announced the expiration of the initial offering period of the tender offer by its wholly-owned subsidiary Thunder Tech Corp. for all outstanding shares of common stock of Third Wave. The initial offering period expired, as scheduled, at 12:00 midnight, New York City time, on Wednesday, July 16, 2008.[More...]

Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer

Wed, 25 Jun 2008 12:56:00 GMT

Hologic, Inc. today announced that the Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended , on June 24, 2008, in connection with Hologic's previously announced tender offer for all of the outstanding shares of the common stock of Third Wave Technologies, Inc. . The early termination of the waiting period under the HSR Act satisfies the conditions to the tender offer related to the expiration or termination of any applicable waiting periods under the HSR Act and other state and foreign regulatory laws relating to the restraint of trade or lessening of competition. The tender offer remains subject to certain other conditions described in the Offer to Purchase.[More...]

Hologic to Acquire Third Wave Technologies

Mon, 09 Jun 2008 10:40:00 GMT

Hologic, Inc. , of Bedford, Mass., announced today that it has signed a definitive agreement to acquire Third Wave Technologies, Inc. for a purchase price of $11.25 per share, or approximately $580 million in value, representing an approximately 24% premium to Third Wave's average trading price over the last three months. The Boards of Directors of both companies unanimously approved the transaction in which Hologic is to acquire 100% of Third Wave's stock in a cash tender offer to be followed by a merger to acquire any untendered shares. The transaction, completion of which is anticipated in the third calendar quarter of 2008, is expected to be modestly dilutive to Hologic's adjusted earnings per share in the first full year after closing, and increasingly accretive thereafter.[More...]

Third Wave Strengthens Core Intellectual Property Portfolio - Jun 1 2008 4:33AM

Fri, 30 May 2008 11:26:00 GMT

Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it has agreed to acquire Stratagene’s Full Velocity family of worldwide patents and patent applications from Agilent Technologies Inc., Santa Clara, Calif.[More...]

New Analyst Reports for THIRD WAVE TECHNOLOGIES INC, INTROGEN THERAPEUTICS INC, MIDDLEBROOK PHARMACEUTICALS INC, and INVITROGEN CORPORATION

Thu, 29 May 2008 17:26:00 GMT

New Analyst Reports for THIRD WAVE TECHNOLOGIES INC, INTROGEN THERAPEUTICS INC, MIDDLEBROOK PHARMACEUTICALS INC, and INVITROGEN CORPORATION[More...]

Third Wave to Present at Baird's 2008 Growth Stock Conference - Jun 30 2008 7:38PM

Tue, 13 May 2008 23:13:00 GMT

Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that it will present at R.W. Baird’s 2008 Growth Stock Conference, which is being held May 13-15, 2008, at the Four Seasons Hotel Chicago. Kevin T. Conroy, Third Wave's president and chief executive, will make the company’s presentation at 12:40 p.m. CT on Wednesday, May 14.[More...]

Third Wave to Present at 33rd Annual Deutsche Bank Health Care Conference - Jun 30 2008 7:38PM

Thu, 01 May 2008 18:56:00 GMT

Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it will present at the 33rd Annual Deutsche Bank Health Care Conference, which is being held May 5-7, 2008, at the InterContinental Hotel in Boston. Maneesh K. Arora, Third Wave's senior vice president and chief financial officer, will make the company’s presentation at 3:30 p.m. EDT on Tuesday, May 6.[More...]

Third Wave Reports First-Quarter Financial Results - Jun 30 2008 7:38PM

Thu, 01 May 2008 11:05:00 GMT

Third Wave Technologies Inc. (NASDAQ: TWTI) today announced its financial results for the quarter ended March 31, 2008.[More...]

Third Wave Completes FDA Submissions for Its Two HPV Products

Mon, 28 Apr 2008 13:55:00 GMT

Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company has submitted the pre-market approval (PMA) applications for its two human papillomavirus, or HPV, testing products to the U.S. Food and Drug Administration.[More...]